Stopping cholesterol-lowering drugs could be deadly
Andrew M. Seaman
(Reuters Health) - Stopping a cholesterol-lowering drug because of a muscle ache or stomach pain can be dangerous in the long run, suggests a new study.
Researchers found that people who stopped taking statins after reporting a side effect were 13 percent more likely to die or have a heart attack or stroke over the next four years than people who kept taking the drugs.
Statins include the drugs atorvastatin, known commercially as Lipitor; rosuvastatin, also known as Crestor, and simvastatin, or Zocor.
They work by inhibiting the liver's ability to produce cholesterol while also helping the organ remove existing fats in the blood, according to the U.S. Centers for Disease Control and Prevention.
Andrew M. Seaman
(Reuters Health) - Stopping a cholesterol-lowering drug because of a muscle ache or stomach pain can be dangerous in the long run, suggests a new study.
Researchers found that people who stopped taking statins after reporting a side effect were 13 percent more likely to die or have a heart attack or stroke over the next four years than people who kept taking the drugs.
Statins include the drugs atorvastatin, known commercially as Lipitor; rosuvastatin, also known as Crestor, and simvastatin, or Zocor.
They work by inhibiting the liver's ability to produce cholesterol while also helping the organ remove existing fats in the blood, according to the U.S. Centers for Disease Control and Prevention.
Continue reading @ Reuters Health
Recommended Reading
Michael Carter / 18 April 2017
Treatment with statins reduces the risk of decompensated liver disease for people with cirrhosis caused by hepatitis B virus (HBV) and hepatitis C virus (HCV), investigators from Taiwan report in the online edition
Continue reading.....
Treatment with statins reduces the risk of decompensated liver disease for people with cirrhosis caused by hepatitis B virus (HBV) and hepatitis C virus (HCV), investigators from Taiwan report in the online edition
Continue reading.....
No comments:
Post a Comment